A round of Series D financing involving 39 investors pulled in $280.2 million for San Carlos, Calif.-based Auris Surgical Robotics, bringing the company closer to its $285.1 million goal. Auris said the first target for its technology is diagnosis of early-stage lung cancer.
Funding round brings in $280.2M for Auris Surgical
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.